Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

Combination antiretroviral therapy (cART) administered shortly after human immunodeficiency virus type 1 (HIV-1) infection can suppress viremia and limit seeding of the viral reservoir, but lifelong treatment is required for the majority of patients. Highly potent broadly neutralizing HIV-1 monoclon...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Virol
Autori principali: Bolton, Diane L., Pegu, Amarendra, Wang, Keyun, McGinnis, Kathleen, Nason, Martha, Foulds, Kathryn, Letukas, Valerie, Schmidt, Stephen D., Chen, Xuejun, Todd, John Paul, Lifson, Jeffrey D., Rao, Srinivas, Michael, Nelson L., Robb, Merlin L., Mascola, John R., Koup, Richard A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2016
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4719604/
https://ncbi.nlm.nih.gov/pubmed/26581981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02454-15
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi